Drug Interactions between Dextran 70 6% in 5% Dextrose and ferrous sulfate
This report displays the potential drug interactions for the following 2 drugs:
- Dextran 70 6% in 5% Dextrose (dextran, high molecular weight)
- ferrous sulfate
Interactions between your drugs
No interactions were found between Dextran 70 6% in 5% Dextrose and ferrous sulfate. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Dextran 70 6% in 5% Dextrose
A total of 32 drugs are known to interact with Dextran 70 6% in 5% Dextrose.
- Dextran 70 6% in 5% dextrose is in the drug class plasma expanders.
- Dextran 70 6% in 5% dextrose is used to treat Bleeding Disorder.
ferrous sulfate
A total of 88 drugs are known to interact with ferrous sulfate.
- Ferrous sulfate is in the drug class iron products.
- Ferrous sulfate is used to treat the following conditions:
Drug and food interactions
ferrous sulfate food
Applies to: ferrous sulfate
ADJUST DOSING INTERVAL: Concomitant use of some oral medications may reduce the bioavailability of orally administered iron, and vice versa.
Food taken in conjunction with oral iron supplements may reduce the bioavailability of the iron. However, in many patients intolerable gastrointestinal side effects occur necessitating administration with food.
MANAGEMENT: Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect. Some studies suggest administration of iron with ascorbic acid may enhance bioavailability. In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased. Consult the product labeling for specific separation times and monitor clinical responses as appropriate.
References (2)
- "Product Information. Feosol (ferrous sulfate)." SmithKline Beecham
- (2021) "Product Information. Accrufer (ferric maltol)." Shield Therapeutics
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.